InsidersTradesSigma
Atrys Health, S.A.: directors' dealings · Spain · CNMV
CNMV:atrys-health-saES0105148144ES·CNMVMcap 205M€Healthcare & Pharma
Explore the full management transaction log of Atrys Health, S.A., a publicly traded company based in Spain. Shares trade on ES ES, under the supervision of CNMV. Operating in the Healthcare & Pharma sector, Atrys Health, S.A. has recorded 53 insider filings. Market capitalisation: €204.6m. The latest transaction was filed on 23 April 2026 (Sale). Among the most active insiders: Santiago de Torres Sanahuja. The full history is openly available.
53
Insider Decl.
0
Thresholds
€6m
42 ops.
Buy Volume
€26m
11 ops.
Sell Volume
Financial data
Analyst consensus
3 analysts4.00 €Target 4.83 €5.50 €
Valuation
PER (forward)25.5x
P/Book1.3x
Beta0.55
Balance sheet & cash
Market cap204.6 M€
Debt / Equity170%
Profitability & ownership
ROE-27.5%
ROA-1.2%
% insiders54.6%
% institutions5.6%
Last declaration on 23 April 2026
Declarations53 total
Executives●Sale21CNMV
€14,9505,000 shares@ €2.990.0073% mcap50.0% of flow
ShareXMAD
CNMV:2026056017·
Executives●Purchase21CNMV
€14,9505,000 shares@ €2.990.0073% mcap50.0% of flow
ShareXMAD
CNMV:2026051348·
Ideal exit: 10 Jan 2027 (T+270)
Executives●Sale28CNMV
€11,0004,000 shares@ €2.750.0054% mcap100.0% of flow
ShareXMAD
CNMV:2026048808·
Executives●Purchase29CNMV
€29,70011,000 shares@ €2.700.015% mcap36.9% of flow
ShareXMAD
CNMV:2026048065·
Ideal exit: 26 Dec 2026 (T+270)
Executives●Purchase32CNMV
€50,76018,000 shares@ €2.820.025% mcap63.1% of flow
ShareXMAD
CNMV:2025141315·
Ideal exit: 14 Aug 2026 (T+270)
Executives●Sale11CNMV
€3,8601,000 shares@ €3.860.0019% mcap100.0% of flow
ShareXMAD
CNMV:2024075458·
Executives●Purchase9CNMV
€14,5005,000 shares@ €2.900.0071% mcap10.1% of flow
ShareBMEX
CNMV:2024065780·
Ideal exit: 4 Feb 2025 (T+270)
Executives●Purchase8CNMV
€1,444399 shares@ €3.620.0007% mcap1.0% of flow
ShareBMEX
CNMV:2024065794·
Ideal exit: 8 Feb 2025 (T+270)
Executives●Purchase9CNMV
€14,5005,000 shares@ €2.900.0071% mcap10.1% of flow
ShareBMEX
CNMV:2024065281·
Ideal exit: 4 Feb 2025 (T+270)
Executives●Purchase21CNMV
€111,30933,730 shares@ €3.300.054% mcap77.7% of flow
ShareBMEX
CNMV:2024065287·
Ideal exit: 7 Feb 2025 (T+270)
Executives●Purchase8CNMV
€1,444399 shares@ €3.620.0007% mcap1.0% of flow
ShareBMEX
CNMV:2024065295·
Ideal exit: 8 Feb 2025 (T+270)
Executives●Purchase22CNMV
€3,9201,000 shares@ €3.920.0019% mcap17.0% of flow
ShareXMAD
CNMV:2023136120·
Ideal exit: 16 Aug 2024 (T+270)
Executives●Purchase24CNMV
€24862 shares@ €4.000.0001% mcap11.7% of flow
ShareXMAD
CNMV:2023124870·
Ideal exit: 13 Jul 2024 (T+270)
Executives●Purchase23CNMV
€10426 shares@ €4.000.0001% mcap4.9% of flow
ShareXMAD
CNMV:2023124883·
Ideal exit: 1 Jul 2024 (T+270)
Executives●Purchase22CNMV
€3,8901,000 shares@ €3.890.0019% mcap16.8% of flow
ShareXMAD
CNMV:2023117179·
Ideal exit: 25 Jun 2024 (T+270)
Executives●Purchase22CNMV
€24,7005,000 shares@ €4.940.012% mcap100.0% of flow
ShareXMAD
CNMV:2023105251·
Ideal exit: 22 Apr 2024 (T+270)
Executives●Purchase24CNMV
€21443 shares@ €4.980.0001% mcap10.1% of flow
ShareXMAD
CNMV:2023060092·
Ideal exit: 15 Jan 2024 (T+270)
Executives●Purchase24CNMV
€11523 shares@ €5.020.0001% mcap5.5% of flow
ShareXMAD
CNMV:2023060093·
Ideal exit: 14 Jan 2024 (T+270)
Executives●Purchase24CNMV
€15230 shares@ €5.080.0001% mcap7.2% of flow
ShareXMAD
CNMV:2023060094·
Ideal exit: 13 Jan 2024 (T+270)
Executives●Purchase27CNMV
€762150 shares@ €5.080.0004% mcap36.1% of flow
ShareXMAD
CNMV:2023060095·
Ideal exit: 12 Jan 2024 (T+270)
Executives●Purchase24CNMV
€16532 shares@ €5.150.0001% mcap7.8% of flow
ShareXMAD
CNMV:2023060098·
Ideal exit: 9 Jan 2024 (T+270)
Executives●Purchase23CNMV
€7514 shares@ €5.360.0000% mcap3.6% of flow
ShareXMAD
CNMV:2023060099·
Ideal exit: 7 Jan 2024 (T+270)
Executives●Purchase24CNMV
€27752 shares@ €5.330.0001% mcap13.1% of flow
ShareXMAD
CNMV:2023060100·
Ideal exit: 30 Jan 2024 (T+270)
Executives●Purchase9CNMV
€7,7411,506 shares@ €5.140.0038% mcap6.0% of flow
ShareXMAD
CNMV:2023059129·
Ideal exit: 30 Jan 2024 (T+270)
Executives●Purchase21CNMV
€120,75923,494 shares@ €5.140.059% mcap94.0% of flow
ShareXMAD
CNMV:2023058588·
Ideal exit: 29 Jan 2024 (T+270)
25 of 53 declarations
About Atrys Health, S.A.
ATRYS HEALTH, S.A. is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for the diagnosis and treatment of diseases. It is listed on the XMAD market.
